Søgeord

Søgning på udtrykket 'covid' giver 58 resultater

Dokumenter [2] Sider [4] Kalender [11] Nyt fra tidsskrifterne [20] Aktuelle smitsomme sygdomme [20]

Dokumenter [2]

Version 13 (13.05.2021). Denne vejledning er tiltænkt initial diagnostik og behandling af formodet COVID-19. Virussygdommen er først beskrevet i januar 2020, og der er endnu sparsom evidens på en række områder. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau.

Version 3.1 Antiviralt middel til behandling af hypoksisk COVID-19 pneumoni Udarbejdet af Tværregionalt Forum for Koordination af Medicin, Danske Regioner og Netværksgruppen af infektionsmedicinske afdelinger


Sider [4]

| Se eller gense udvalgte præsentationer fra COVID-19 fyraftensmøderne. |  

…Fertilitetsbehandling ved HIV og hepatitis B og C HIV behandling af gravide HIV post exposure profylakse (PEP) Pre-exposure profylakse mod HIV (PrEP) Borrelia Anne-Mette Lebech, Sigurdur Skarphedinsson Borrelia klaringsrapport COVID-19 Marie Helleberg/Jens Lundgren, Lothar Wiese, Michael Dalager-Pedersen, Merete Storgaard, Isik Somuncu Johansen og Gitte Kronborg COVID-19 retningslinje Remdesivir DRG-udvalg Bjarne Ørskov Lindhardt Endokarditis Jannik H…

| Se eller gense udvalgte præsentationer fra COVID-19 fyraftensmøderne. |  


Kalender [11]

31.08.2021, Holst Auditoriet, Mærsk Tårnet, København
22.03.2021, Online
18.06.2020, Aflyst på grund af COVID-19
3.06.2020, Mødet udskudt på grund af COVID-19

Nyt fra tidsskrifterne [20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Current Opinion in Infectious Diseases
1.08.2021
No abstract available
Current Opinion in Infectious Diseases
1.08.2021
Purpose of review There likely are several predisposing factors to secondary infections in patients with Coronavirus disease 2019 (COVID-19), some of which may be preventable. The aim of this review is to explore the literature, summarize potential predisposing factors to secondary infections and their incidence. It also summarizes a variety of healthcare scenarios in which different kinds of secondary infections occur. Recent findings Apart from immune dysregulation, severe resource limitations in hea…
Current Opinion in Infectious Diseases
1.08.2021
Purpose of review The coronavirus disease (COVID-19) pandemic has resulted in necessary modifications of infection control policies and practices in acute healthcare facilities globally. This is often accompanied by infrastructure modifications, ward redesignations, as well as healthcare staff redeployments and changes to infection prevention and control (IPC) practices. We review the potential for both negative and positive impacts these major changes can have on nosocomial transmission of multidrug-resi…
Lancet Infectious Diseases
27.07.2021
Aerosolised Ad5-nCoV is well tolerated, and two doses of aerosolised Ad5-nCoV elicited neutralising antibody responses, similar to one dose of intramuscular injection. An aerosolised booster vaccination at 28 days after first intramuscular injection induced strong IgG and neutralising antibody responses. The efficacy and cost-effectiveness of aerosol vaccination should be evaluated in future studies.
BMJ Open
26.07.2021
Objective To analyse the epidemiological characteristics of family clusters of COVID-19 and the three stages of the comprehensive non-pharmaceutical interventions and measures implemented in Shenzhen. Methods The epidemic curve of COVID-19 was drawn and the impact of the comprehensive non-pharmaceutical interventions and measures was analysed by the different periods of the epidemic. Results A total of 427 cases (417 confirmed cases and 10 asymptomatic infectious cases) were reported in Shenzhen, of whi…
BMJ Open
26.07.2021
Introduction COVID-19 has a serious impact on people’s physical health and mental health. The COVID-19 pandemic forced college and university students to take online classes, which may have bad impacts on students’ learning. In addition, the students lost many job opportunities during the pandemic. Faced with employment and study pressure and worried about the epidemic, college and university students were prone to increased overall negative emotion, anxiety and depression. Therefore, this syste…
PLoS One Infectious Diseases
26.07.2021
…ck, Nina Hiebel, Milena Rabe, Juliane Schneider, Yesim Erim, Eva Morawa, Lucia Jerg-Bretzke, Petra Beschoner, Christian Albus, Julian Hannemann, Kerstin Weidner, Susann Steudte-Schmiedgen, Lukas Radbruch, Holger Brunsch, Franziska Geiser Introduction The COVID-19 pandemic resulted in severe detrimental effects on the mental well-being of health care workers (HCW). Consequently, there has been a need to identify health-promoting resources in order to mitigate the psychological impact of the pandemic on HCW.…
PLoS One Infectious Diseases
26.07.2021
by Murielle Mary-Krause, Joel José Herranz Bustamante, Mégane Héron, Astrid Juhl Andersen, Tarik El Aarbaoui, Maria Melchior Background The outbreak of the COVID-19 epidemic lead to high levels of morbidity and mortality around the globe. Consequences of this outbreak and possible associated infection are an increase in mental health disorders and an increased likelihood of internalizing problems, particularly depression. However, to date few studies have tested this hypothesis while taking into account…
PLoS One Infectious Diseases
26.07.2021
…h, Shay Shilo, Niv Cohen, Nir Erez, Vadim Fedyuk, Alexander M. Schrager, Adina Weinberger, Amiel A. Dror, Asaf Zigron, Mona Shehadeh, Eyal Sela, Samer Srouji, Sharon Amit, Itzchak Levy, Eran Segal, Rony Dahan, Dan Jones, Daniel C. Douek, Efrat Shema The COVID-19 pandemic raises the need for diverse diagnostic approaches to rapidly detect different stages of viral infection. The flexible and quantitative nature of single-molecule imaging technology renders it optimal for development of new diagnostic tools…
PLoS One Infectious Diseases
26.07.2021
by Xiaofeng Liu, Zubair Ahmad, Ahmed M. Gemeay, Alanazi Talal Abdulrahman, E. H. Hafez, N. Khalil Over the past few months, the spread of the current COVID-19 epidemic has caused tremendous damage worldwide, and unstable many countries economically. Detailed scientific analysis of this event is currently underway to come. However, it is very important to have the right facts and figures to take all possible actions that are needed to avoid COVID-19. In the practice and application of big data sciences, it…
PLoS One Infectious Diseases
26.07.2021
by Uday Narayan Yadav, Om Prakash Yadav, Devendra Raj Singh, Saruna Ghimire, Binod Rayamajhee, Sabuj Kanti Mistry, Lal Bahadur Rawal, ARM Mehrab Ali, Man Kumar Tamang, Suresh Mehta Background Coronavirus disease 2019 (COVID-19) has affected all age groups worldwide, but older adults have been affected greatly with an increased risk of severe illness and mortality. Nepal is struggling with the COVID-19 pandemic. The normal life of older adults, one of the vulnerable populations to COVID-19 infection, has be…
PLoS One Infectious Diseases
26.07.2021
by Sanath Kumar Janaka, Natasha M. Clark, David T. Evans, Huihui Mou, Michael Farzan, Joseph P. Connor Background The novel coronavirus SARS-CoV2 that causes COVID-19 has resulted in the death of more than 2.5 million people, but no cure exists. Although passive immunization with COVID-19 convalescent plasma (CCP) provides a safe and viable therapeutic option, the selection of optimal units for therapy in a timely fashion remains a barrier. Study design and methods Since virus neutralization is a necessar…
PLoS One Infectious Diseases
26.07.2021
…Gary C. An, Sean A. Diehl, Jacob G. Scott Personal protective equipment (PPE) is crucially important to the safety of both patients and medical personnel, particularly in the event of an infectious pandemic. As the incidence of Coronavirus Disease 2019 (COVID-19) increases exponentially in the United States and many parts of the world, healthcare provider demand for these necessities is currently outpacing supply. In the midst of the current pandemic, there has been a concerted effort to identify viable w…
BMJ Open
26.07.2021
Objective To examine the value of health systems data as indicators of emerging COVID-19 activity. Design Observational study of health system indicators for the COVID Hotspotting Score (CHOTS) with prospective validation. Setting and participants An integrated healthcare delivery system in Northern California including 21 hospitals and 4.5 million members. Main outcome measures The CHOTS incorporated 10 variables including four major (cough/cold calls, emails, new positive COVID-19 tests, COVID-19 ho…
International Journal of Infectious Diseases
26.07.2021
I would like to express gratitude for reader's interest in previously published manuscript entitled “Pneumonia in medical professionals during COVID-19 outbreak in cardiovascular hospital” in International Journal of Infectious Diseases (Ilic et al., 2021).
BMC Infectious Diseases
26.07.2021
Abstract Background The type of pneumonia that is caused by the new coronavirus (SARS-CoV-2) has spread across the world in a pandemic. It is not clear if COVID-19 patients have any lower urinary tract signs or symptoms. Methods The effect of COVID-19 on lower urinary tract function was studied in a prospective multi-centre, observational study including 238…
International Journal of Infectious Diseases
25.07.2021
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) had caused the current Coronavirus Disease 2019 (COVID-19) pandemic. The pandemic had resulted in a significant disruption of social live and had a major economic impact. Countries around the globe had taken extra-ordinary measures to combat the disease. The results from phase III clinical trials showed that both Pfizer-BioNTech messenger RNA (mRNA) vaccine (BNT162b2) and the Oxford-AstraZeneca adenovirus vector vaccine, ChAdOx1-S, also known …
Clinical Microbiology and Infection
25.07.2021
It was in 1880 when diphtheria toxin was discovered and, shortly after, the treatment of this infectious diseases with the serum of convalescent patients was proposed for the first time(1). Since then, a long chapter has been written in the History of Medicine about the use of serum o plasma containing immunoglobulins for the treatment, pre-emptive therapy or prophylaxis of infectious diseases. In the pandemic of influenza virus infection in 1918, called the Spanish flu, convalescent human serum was used fo…
International Journal of Infectious Diseases
25.07.2021
Although the threat of a pandemic had been expected for years, Covid-19 triggered frantic and uncoordinated reactions worldwide (Independent Panel for Pandemic and Preparedness and Response, 2021; Paul et al., 2020b). Since being declared a public health emergency in January 2020, Covid-19 has been regarded as an exceptional disease, as if it came from outer space. For the first time in history, billions of people were locked down, denied the right to go to school or to earn their living, and/or to see thei…
International Journal of Infectious Diseases
25.07.2021
Dear Sir

Aktuelle smitsomme sygdomme [20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
26.07.2021
'I got 99 problems but a vax ain't one,' he said in a tweet last month.
ProMED
26.07.2021
COVID-19 -- United StatesAn unvaccinated snow leopard at the San Diego Zoo has contracted COVID-19. Caretakers noticed that Ramil, a 9-year-old male snow leopard, had a cough and runny nose on Thursday [22 Jul 2021]. Later, 2 separate tests of his stool confirmed the presence of the coronavirus, the zoo said in a statement Friday [23 Jul 2021]. Ramil is not showing additional symptoms, the zoo said, but because he shares an enclosure with a female snow leopard and 2 Amur leopards, the staff assumes they hav…
Medscape Infectious Diseases
26.07.2021
If a game can't be rescheduled during the regular 18-week season, the team with the outbreak will forfeit the game and receive a 'loss' in standings, the league announced.
Statens Serum Institut
26.07.2021
Nye tal fra Statens Serum Institut viser, at 22% af alle delta-variant-infektioner optræder hos personer der er i perioden fra 14 dage efter første vaccinestik til de får andet stik. Derfor skal folk være opmærksomme på, at de stadig kan blive smittet, og følge de generelle råd om smitteforebyggelse.
ProMED
26.07.2021
COVID-19 -- Worldwide/UnknownThe European Union's medicines regulator has recommended authorising Moderna's COVID-19 vaccine for use in children aged between 12 and 17, marking the 1st time the shot has been approved for people under 18. In a decision on Friday [23 Jul 2021] the European Medicines Agency (EMA) said research in more than 3700 children of 12-17 years of age showed that the shot produced a comparable antibody response to that seen in 18-25-year-olds. Use of the vaccine, Spikevax, will be the s…
ProMED
24.07.2021
COVID-19 -- Worldwide/Unknown"...There have been increases in the incidence of malnutrition among older adults with severe COVID-19 (12-14). This suggests that COVID-19 or its complications may be triggering malnutrition or related physiological processes. This is of crucial importance because malnutrition dampens the immune system, increases mortality, hospital length of stays, and the risk of unplanned hospital readmission (15-17). Furthermore, acute and chronic malnutrition predispose patients to signifi…
ProMED
23.07.2021
COVID-19 -- Worldwide/Unknown1. Borchering RK, Viboud C, Howerton E, et al. Modeling of future COVID-19 cases, hospitalizations, and deaths, by vaccination rates and nonpharmaceutical intervention scenarios -- United States, April-September 2021. MMWR Morb Mortal Wkly Rep. 2021; 70: 719-24. - Mod.LXL] ******[2] Israel: Pfizer vaccine efficacy declineDate: Wed 21 Jul 2021 22:58 IDTSource: The Times of Israel [edited] Vaccine effectiveness in preventing serious COVID-19 infection among the elderly has
Medscape Infectious Diseases
23.07.2021
It's rare for children to die of the coronavirus. The CDC says only 335 of the 600,000 people who have died from COVID-19 in the United States were under 18.
Medscape Infectious Diseases
23.07.2021
Experts evaluate some advantages and caveats regarding seven intranasal COVID-19 vaccines in development.
ProMED
23.07.2021
COVID-19 -- Worldwide/UnknownAbstract--------BACKGROUNDThe B.1.617.2 (delta) variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has contributed to a surge in cases in India and has now been detected across the globe, including a notable increase in cases in the United Kingdom. The effectiveness of the BNT162b2 and ChAdOx1 nCoV-19 vaccines against this variant has been unclear.METHODSWe used a test-negative case-control desi…
Medscape Infectious Diseases
22.07.2021
As COVID-19 hospitalizations rise in areas with low vaccination rates, patients are asking for a vaccine, but it's often "too late," one doctor said.
Medscape Infectious Diseases
22.07.2021
Nationwide, the 7-day rolling average for daily new cases rose over the past 2 weeks to more than 37,000 on July 20, up from less than 13,700 on July 6, according to data from Johns Hopkins University.
Medscape Infectious Diseases
22.07.2021
Pfizer and Moderna are conducting vaccine clinical trials for children ages 6 months to 12 years. Results are expected sometime this fall.
Medscape Infectious Diseases
22.07.2021
Patients with a mental illness, particularly a psychotic or mood disorder, are twice as likely to die after infection with SARS-CoV-2 compared with those without a psychiatric diagnosis.
Morbidity and Mortality Weekly Report (MMWR)
22.07.2021
This report describes the circulation of influenza and other respiratory viruses during the COVID-19 pandemic.
Eurosurveillance latest updates
22.07.2021
Background In South Africa, COVID-19 control measures to prevent SARS-CoV-2 spread were initiated on 16 March 2020. Such measures may also impact the spread of other pathogens, including influenza virus and respiratory syncytial virus (RSV) with implications for future annual epidemics and expectations for the subsequent northern hemisphere winter. Methods We assessed the detection of influenza and RSV through facility-based syndromic surveillance of adults and children with mild or severe respiratory il…
Eurosurveillance latest updates
22.07.2021
The non-pharmaceutical interventions implemented to slow the spread of SARS-CoV-2 have had consequences on the transmission of other respiratory viruses, most notably paediatric respiratory syncytial virus (RSV) and influenza. At the beginning of 2020, lockdown measures in the southern hemisphere led to a winter season with a marked reduction in both infections. Intermittent lockdowns in the northern hemisphere also appeared to interrupt transmission during winter 2020/21. However, a number of southern and …
Eurosurveillance latest updates
22.07.2021
We measured COVID-19 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection at primary care/outpatient level among adults ≥ 65 years old using a multicentre test-negative design in eight European countries. We included 592 SARS-CoV-2 cases and 4,372 test-negative controls in the main analysis. The VE was 62% (95% CI: 45–74) for one dose only and 89% (95% CI: 79–94) for complete vaccination. COVID-19 vaccines provide good protection against COVID-19 presentation at primary care…
Eurosurveillance latest updates
22.07.2021
Following low incidence of respiratory syncytial virus (RSV) infections in 2020 during the COVID-19 pandemic, we noted a resurgence in hospitalised children in spring/summer 2021 following relaxation of public health measures. We compared this outbreak to previous autumn/winter seasons. We found higher weekly case numbers and incidence rates, more cases from urban neighbourhoods with lower socioeconomic status, and similar clinical presentation and severity. Public health implications include the re-evaluat…
ProMED
21.07.2021
COVID-19 -- Worldwide/UnknownAbstract--------SARS-CoV-2 mRNA vaccines, including Pfizer/BioNTech BNT162b2, were shown to be effective for COVID-19 prevention, eliciting both robust antibody responses in naive individuals and boosting pre-existing antibody levels in SARS-CoV-2-recovered individuals. However, the magnitude, repertoire, and phenotype of epitope-specific T cell responses to this vaccine, and the effect of vaccination on pre-existing T cell memory in SARS-CoV-2 convalescent patients, are still p…

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2021 Dansk Selskab for Infektionsmedicin

version: 2.9.0 ● design: C P Fischer

Side indlæst på 0,7 s

Cookies og privatliv